Resmed Inc.
(ASX:RMD) says second quarter results have seen a 13 per cent increase in revenue on a constant currency basis.
Revenue was up 7 per cent to $454.5 million compared to the December quarter last year which translates into double digit growth once currency fluctuations are taken into account.
Again it’s the American business which seems to lead sales with good results from the new Air Solutions software. Resmed also says it has now expanded into the field of long term oxygen therapy.
Resmed reported a net profit of $459.48 million for the 2015 financial year.
